Moskva, Moscow, Russian Federation
Moskva, Moscow, Russian Federation
The article presents the data of the randomized clinical trial of 80 young patients with destructive pulmonary tuber-culosis for various methods of TB drugs injection. Particular attention is paid to the role of parenteral drug delivery. The work demonstrated that newly diagnosed patients with destructive pulmonary tuberculosis of younger age the most optimal and effective is parenteral injection of injectable forms of TB drugs, allowing to halt bacterioexcretion for 3 months in 92.5 % of cases and to close cavities in the lungs in 80 %. In newly diagnosed patients with destructive pulmonary tuberculosis of young age oral use of tablets and of TB drugs is not effective enough, allowing to achieve 3 months cessation of bacterial isolation in 85.2 % of cases and to close cavities in the lungs in 42.5 %. Undesirable side reactions to parenteral administration of injectable forms of TB drugs were detected in 17.5 % of patients and to sep-arate oral tablet forms – in 20 %, fatal reactions were observed in 5 % of cases of drug delivery regardless of method.
tuberculosis, drug-resistant of mycobacterium tuberculosis, TB drugs, methods of drug injection
1. VanievEV, VasilyevaIA, AbdullaevRY, ChukanovVI, DaurovRB (2008). The use of fluoroquinolones in the intensive phase of treatment for newly diagnosed pa-tients with destructive lung tuberculosis [Ispol’zovanie ftorkhinolonov v intensivnoy faze lecheniya vpervye vyyavlennykh bol’nykh destruktivnym tuberkulezom legkikh]. Problemy tuberkuleza i bolezni legkikh, (10), 57-60.
2. GordinaAV, ZaychenkoNM, KucheryavayaDA, NechayevaOB, SonIM, SterlikovSA, OdintsovVE (2015). Resources and activity of anti-TB institutions of the Rus-sian Federation in 2013-2014 (statistical materials) [Re-sursy i deyatel’nost’ protivotuberkuleznykh organizatsiy Rossiyskoy Federatsii v 2013-2014 gg. (statisticheskie materialy)], 89
3. KelasovaNV, AksenovaVА (2007). The effectiveness of “Lomekomb” treatment of young patients with pulmo-nary tuberculosis [Effektivnost’ lecheniya preparatom «Lomekomb» molodykh bol’nykh tuberkulezom legkikh]. Vrach, (8), 32-33
4. KononetsAS, MishinVY (2008). The effectiveness of the treatment of newly diagnosed pulmonary tu-berculosis patients with high level of drug resistance [Effektivnost’ lecheniya vpervye vyyavlennykh bol’nykh tuberkulezom legkikh s vysokim urovnem razvitiya le-karstvennoy ustoychivosti vozbuditelya]. Infektsionnye bolezni, 6(4), 68-71
5. LevashovYN, MishinVY, KrasnovVA, StepanovDV, SvistelnikAV, SmerdinSV, MokhirevaLV (2009). Mul-ticenter study of the effectiveness of IIb chemotherapy mode with the use of combined drug “Lomekomb” in the treatment of patients with newly diagnosed MbT+ pulmonary tuberculosis [Mnogotsentrovye issledovaniya effektivnosti IIb rezhima khimioterapii s ispol’zovaniem kombinirovannogo preparata lomekomb pri lechenii vpervye vyyavlennykh bol’nykh tuberkulezom legkikh s bakteriovydeleniem]. Tezisy dokladov XVI Rossiyskogo natsional’nogo kongressa «Chelovek i lekarstvo», 157.
6. MishinVY (2007). Pulmonary tuberculosis with drug-resistant pathogen [Tuberkulez legkikh s lekarst-vennoy ustoychivost’yu vozbuditelya], 197.
7. MishinVY, MyakishevaTV, AmaraevaLV, An-drianovaAY, BorovitskiVS, LomovaLA, LuzinaNV, MishinaAV, OsintsevIY, ChurinaEG (2011). The effective-ness of treatment of patients with destructive pulmonary tuberculosis at parenteral and oral anti-TB drugs appli-cation [Effektivnost’ lecheniya bol’nykh destruktivnym tuberkulezom legkikh bol’nykh pri parenteral’nom i per-oral’nom primenenii protivotuberkuleznykh preparatov]. Pul’monologiya, (1), 55-59.
8. MishinVY (2014). On the contradictions in the Russian clinical recommendations for chemotherapy in pulmonary tuberculosis patients from the point of evidence-based medicine: meta-analysis and systematic review of literature [O protivorechiyakh v Rossiyskikh klinicheskikh rekomendatsiyakh po khimioterapii bol’nykh tuberkulezom legkikh s pozitsiy dokazatel’noy meditsiny: metaanaliz i sistematicheskiy obzor literatury]. Pul’monologiya, (4), 80-90.
9. OvsyankinaES, FirsovaVA, GubkinaMF, Kobulash-viliMG, OkhorzinaNA (2008). Regional lymphotropic injection of drugs in the differential diagnosis and complex treatment of tuberculosis in adolescents: Guidance Man-ual [Primenenie regional’nogo limfotropnogo vvedeniya lekarstvennykh preparatov v differentsial’noy diagnostike i kompleksnom lechenii tuberkuleza u podrostkov: Meto-dicheskoe posobie TsNIIT RAMN], 18
10. RabukhinAE (1970). Chemotherapy of pulmonary tuberculosis patients [Khimioterapiya bol’nykh tuberku-lezom legkikh], 400.
11. PerelmanMA (2007). Phthisiology. National guide-lines [Ftiziatriya. Natsional’noe rukovodstvo], 506.
12. Federal guidelines on the use of drugs (formulary sys-tem) (2016) [Federal’noe rukovodstvo po ispol’zovaniyu le-karstvennykh preparatov (formulyarnaya sistema)], 699-706.
13. KhomenkoAG (1980). Chemotherapy of pulmonary tuberculosis [Khimioterapiya tuberkuleza legkikh], 279.
14. ShilovaMV (2015). Tuberculosis in Russia in 2014 [Tuberkulez v Rossii v 2014 godu], 236.
15. Drug-resistant tuberculosis (2011). A survival guide for clinicians, 2nd ed., 266. Available at: http://www.currytbcenter.ucsf.edu/drtb/drtb_ch3.cfm
